Advertisement

Topics

WaVe Life Sciences Company Profile

03:26 EST 19th December 2018 | BioPortfolio

WaVe Life Sciences is leading a revolution in nucleic acid therapeutics and was founded on the core principle that medicines should possess precisely controlled molecular structures. We and our strategic partners are advancing a portfolio of stereopure drug candidates that target underlying biology across a wide range of human diseases. www.wavelifesciences.com


News Articles [2227 Associated News Articles listed on BioPortfolio]

Wave Life Sciences plans to design treatments for genetic eye diseases

US-based biotechnology firm Wave Life Sciences has revealed plans to develop new therapeutics for the potential treatment of various rare,...Read More... The post Wave Life Sciences plans to design tr...

Orphan drug, rare pediatric disease statuses given to Wave's DMD therapy

Wave Life Sciences' WVE-210201, being developed as a treatment for patients with Duchenne muscular dystrophy, received orphan -More- 

IPO Wave Rolls On as Five Life Science Firms Haul in $651M

A week after seven biotechs went public, setting a new record for the Nasdaq, five more life sciences companies have joined the club. The latest crop continued the positive momentum for life sciences ...

Wave Life Sciences’ WVE-210201 Granted Orphan Drug and Rare Pediatric Disease Designations from the FDA for Treatment of DMD

CAMBRIDGE, Mass., Aug. 16, 2018 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (NASDAQ: WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, gene...

Wave Life Sciences to Develop Programs in Rare, Genetic Eye Diseases

Research will focus on inherited retinal diseases associated with RHO, USH2A, ABCA4 and CEP290              Initial development candidate expected in H2 2019 CAMBRIDGE, Mass., Oct. 09, 20...

Wave Life Sciences to Present at the Jefferies 2018 London Healthcare Conference

CAMBRIDGE, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, geneti...

Wave Life Sciences Reports Third Quarter 2018 Financial Results and Provides Business Update

CAMBRIDGE, Mass., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, geneti...

Wave Life Sciences Reports Second Quarter 2018 Financial Results and Provides Business Update

CAMBRIDGE, Mass., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, geneti...

PubMed Articles [3403 Associated PubMed Articles listed on BioPortfolio]

The protective effect of low-energy shock wave on testicular ischemia-reperfusion injury is mediated by the PI3K/AKT/NRF2 pathway.

Testicular ischemia-reperfusion (IR) injury is the primary pathophysiological consequence of testicular torsion. Low-energy shock wave (LESW) is an effective treatment for certain diseases. The presen...

Systemic and Reflexive: Foundations of Cumulative Dis/Advantage and Life-Course Processes.

Post-Retirement Life Satisfaction and Financial Vulnerability: The Moderating Role of Control.

This paper examines changes in life satisfaction around retirement exits for those with varying pre-retirement incomes, testing whether constraints on control and control over finances moderate the re...

Early-Life Adversity and Dysregulation of Adult Diurnal Cortisol Rhythm.

Exposure to life stresses can lead to diminution in the capacity of stress response systems to mount a robust response to new challenges, with blunting of dynamic range - the spread between maximal at...

Early-Life Military Exposures and Functional Impairment Trajectories Among Older Male Veterans: The Buffering Effect of Psychological Resilience.

Drawing on the life course framework and theoretical concept of resilience, we examine the impact of early-life service-related exposures (SREs) on later-life functional impairment trajectories among ...

Clinical Trials [2738 Associated Clinical Trials listed on BioPortfolio]

T-Wave Alternans in Patients With Suspected Acute Coronary Syndrome

The purpose of this study is to measure T-Wave Alternans (TWA) in patients with acute coronary syndrome. Researchers are blinded to clinical TWA measurements. The investigators will then...

Intracardiac T-wave Alternans and Ischemia

T-wave alternans is a test that looks at microvolt changes in the T-wave on a beat to beat basis. The presence or absence of such changes has been shown to predict or exclude future arrhy...

T-Wave Alternans in Acute Myocardial Infarction: An Evaluation of the Time of Testing on Its Prognostic Accuracy

T-wave alternans is an electrocardiographic finding that has been shown to predict the occurrence of future cardiac arrhythmias in patients who have had a heart attack. What is unknown ab...

Hepatitis B and HIV Co-Infection in Patients in Uganda

This study will determine the amount of liver scarring (fibrosis) or liver damage in people infected with 1) hepatitis B virus (HBV, a virus that can infect the liver); 2) HIV (the virus t...

Calcinosis Cutis: Therapeutic Effects of Extracorporeal Shock Wave Therapy (ESWT)

Patients with calcinosis cutis due to connective tissue disease get a shock wave therapy. The shock wave therapy will be done in 3 sessions with one week interval. The outcome parameters a...

Companies [2092 Associated Companies listed on BioPortfolio]

WaVe Life Sciences

WaVe Life Sciences is leading a revolution in nucleic acid therapeutics and was founded on the core principle that medicines should possess precisely controlled molecular structur...

WAVE Life Sciences Ltd.

WAVE Life Sciences is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeut...

V-Wave Ltd.

V-Wave is a privately held company with offices in Israel and the U.S. The major investors are Israeli venture firms BRM Group and Pontifax. For further information on V-Wave, vis...

Life Sciences Pennsylvania

Life Sciences Pennsylvania is the statewide trade association for the life sciences in Pennsylvania and serves as a catalyst to ensure Pennsylvania is a global leader in the life ...

Central Life Sciences

Central Life Sciences is a strategic business unit of Central Garden & Pet (NASDAQ: CENT). Central Life Sciences is dedicated to creating healthier environments and making life better for people, ...

More Information about "WaVe Life Sciences" on BioPortfolio

We have published hundreds of WaVe Life Sciences news stories on BioPortfolio along with dozens of WaVe Life Sciences Clinical Trials and PubMed Articles about WaVe Life Sciences for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of WaVe Life Sciences Companies in our database. You can also find out about relevant WaVe Life Sciences Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record